Navegar

Colección

Datos Estadísticas

Lista de

drug development
10
"Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead" (2018) Grotz, E.;Tateosian, N.;Amiano, N. (...)Moretton, M.A. Pharmaceutical Research. 35(11)
"Solvents to fragments to drugs: MD applications in drug design" (2018) Defelipe, L.A.;Arcon, J.P.;Modenutti, C.P. (...)Barril, X. Molecules. 23(12)
"A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases" (2016) Berenstein, A.J.; Magariños, M.P.; Chernomoretz, A.; Agüero, F. PLoS Neglected Tropical Diseases. 10(1)
"A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis" (2016) Defelipe, L.A.;Do Porto, D.F.;Pereira Ramos, P.I. (...)Marti, M.A. Tuberculosis. 97:181-192
"Fluorination methods in drug discovery" (2016) Yerien, D.E.; Bonesi, S.; Postigo, A. Organic and Biomolecular Chemistry. 14(36):8398-8427
"Antiviral activity of natural and synthetic β-carbolines against dengue virus" (2016) Quintana, V.M.;Piccini, L.E.;Panozzo Zénere, J.D. (...)Castilla, V. Antiviral Research. 134:26-33
"Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1" (2015) Dávola, M.E.;Mazaira, G.I.;Galigniana, M.D. (...)Barquero, A.A. Antiviral Research. 122:55-63